EoCene Ltd. (EOCN) stock
EOCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 31, 2026Score 5/30
$2.20−0.26 (-10.63%)
Close on Nov 18, 2026Market cap $2.20MP/E –Yield –
Earnings
EoCene's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q3 FY2025
–
EPS, Q3 FY2025
$0.33
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of EoCene's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | Nov 26, 2025before the open | – | – | $0.33 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 28, 2025before the open | – | – | $0.63 | Release |
| Q1 FY2025ended Mar 31, 2025 | May 22, 2025before the open | – | – | $0.62 | Release |
| Q1 FY2023ended Mar 31, 2023 | Jun 1, 2023before the open | – | – | $1.09 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022before the open | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 2, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
EoCene has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When EoCene puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases EoCene filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?